Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Pediatric Nephrology (Berlin, Germany)|April 1, 1993
Correlation of ultrasound and renal scintigraphy in children with unilateral hydronephrosis in primary workupE U Nitzsche, L B Zimmerhackl, R A Hawkins, et al.Kidney International|June 16, 2006
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disordersN Besbas, D Karpman, D Landau, et al.Therapeutic Drug Monitoring|October 16, 1999
Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, T Lamersdorf, M Shipkova, et al.Journal of the American Society of Nephrology : JASN|August 11, 1998
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, M Shipkova, T Lamersdorf, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 24, 2006
[Surveillance of infectious foodborne diseases after enactment of the German Protection against Infection Act in 2001. Potentials and requirements]D Werber, M H Kramer, U Buchholz, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2012
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndromeJohannes Hofer, Andreas R Janecke, L B Zimmerhackl, et al.Pediatric Nephrology (Berlin, Germany)|January 17, 2002
The use of mycophenolate mofetil suspension in pediatric renal allograft recipientsT Bunchman, M Navarro, M Broyer, et al.The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.Pageof 6